Live birth after using assisted reproductive technologies in a late reproductive-aged female patient with her own oocytes without preimplantation genetic testing for aneuploidies

DOI

https://dx.doi.org/10.18565/aig.2023.60

Khachatryan L.V., Smolnikova V.Yu., Makarova N.P.
1) V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia; 2) I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia

Background: The present-day social conditions set new trends in changing the age model of birth rates with the implementation of reproductive function at a later stage, which creates a number of medical and social problems. проблем. Late reproductive aged women the most frequently face failures in the treatment of infertility by assisted reproductive technologies (ART). In addition, the women of this age cohort have high rates of pregnancy complications and perinatal morbidity.
Case report: The paper describes a clinical case of a favorable outcome of infertility treatment by ART methods using the standard short protocol with gonadotropin-releasing antagonists in a married couple of late reproductive age (the wife is 44 years; the husband is 58 years).
Conclusion: This case shows the possibility of achieving clinical pregnancy with the birth of a healthy baby in even female patients of late reproductive age, which emphasizes the need to optimize ovulation stimulation protocols and to choose the most appropriate method of infertility treatment for each married couple individually. At the same time, it is necessary to provide these married couples with information about the extremely low chances of clinical pregnancy and live birth in the treatment of infertility with ART methods and their own oocytes, as well as about the fertility preservation opportunities, including those using deferred motherhood at an earlier reproductive age.

Authors' contributions: Khachatryan L.V., Smolnikova V. Yu., Makarova N.P. – development of the concept of the investigation, search, review, and analysis of publications on the topic of the article, writing the text of the article.
Conflicts of interest: The authors declare that there are no conflicts of interests.
Funding: The investigation has not been sponsored.
Patient Consent for Publication: The patients have signed an informed consent form to the publication of their data.
For citation: Khachatryan L.V., Smolnikova V.Yu., Makarova N.P. Live birth after using assisted reproductive technologies in a late reproductive-aged female patient with
her own oocytes without preimplantation genetic testing for aneuploidies.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; (7): 175-179 (in Russian)
https://dx.doi.org/10.18565/aig.2023.60

assisted reproductive technologies (ART)

optimization of ART programs

in vitro fertilization (IVF)

late reproductive age

clinical case

Full text (in Russian)

Delbaere I., Verbiest S., Tydén T. Knowledge about the impact of age on fertility: a brief review. Ups. J. Med. Sci. 2020; 125(2): 167-74. https://dx.doi.org/10.1080/03009734.2019.1707913.
Lancaster E.E., Lapato D.M., Jackson-Cook C., Strauss J.F. 3rd, Roberson-Nay R., York T.P. Maternal biological age assessed in early pregnancy is associated with gestational age at birth. Sci. Rep. 2021; 11(1): 15440.https://dx.doi.org/10.1038/s41598-021-94281-7.
Saccone G., Gragnano E., Ilardi B., Marrone V., Strina I., Venturella R., Berghella V., Zullo F. Maternal and perinatal complications according to maternal age: A systematic review and meta-analysis. Int. J. Gynaecol. Obstet. 2022; 159(1): 43-55. https://dx.doi.org/10.1002/ijgo.14100.
Lebovitz O., Haas J., Mor N., Zilberberg E., Aizer A., Kirshenbaum M. et al. Predicting IVF outcome in poor ovarian responders. BMC Womens Health. 2022; 22(1): 395. https://dx.doi.org/10.1186/s12905-022-01964-y.
Camaioni A., Ucci M.A., Campagnolo L., De Felici M., Klinger F.G.; Italian Society of Embryology, Reproduction and Research (SIERR). The process of ovarian aging: it is not just about oocytes and granulosa cells. J. Assist. Reprod. Genet. 2022; 39(4): 783-92. https://dx.doi.org/10.1007/s10815-022-02478-0.
Yan F., Zhao Q., Li Y., Zheng Z., Kong X., Shu C. et al. The role of oxidative stress in ovarian aging: a review. J. Ovarian Res. 2022; 15(1): 100. https://dx.doi.org/ https://dx.doi.org/10.1186/s13048-022-01032-x.
Ma L., Lu H., Chen R., Wu M., Jin Y., Zhang J., Wang S. Identification of key genes and potential new biomarkers for ovarian aging: A Study Based on RNA-Sequencing Data. Front. Genet. 2020; 11: 590660. https://dx.doi.org/10.3389/fgene.2020.590660.
Tesarik J., Galán-Lázaro M., Mendoza-Tesarik R. Ovarian aging: molecular mechanisms and medical management. Int. J. Mol. Sci. 2021; 22(3): 1371. https://dx.doi.org/10.3390/ijms22031371.
Yang L., Chen Y., Liu Y., Xing Y., Miao C., Zhao Y. et al. The role of oxidative stress and natural antioxidants in ovarian aging. Front. Pharmacol. 2021;11:617843. https://dx.doi.org/110.3389/fphar.2020.617843.
Агаджанян Д.С., Смольникова В.Ю., Красный А.М., Лобанова Н.Н., Щипицына В.С., Садекова А.А., Макарова Н.П., Калинина Е.А. Оценка маркеров окислительного стресса у женщин с бесплодием в программах вспомогательных репродуктивных технологий. Акушерство и гинекология. 2022; 9: 64-70. [Agadzhanyan D.S., Smolnikova V.Yu., Krasnyi A.M.,Lobanova N.N., Shchipitsyna V.S., Sadekova A.A., Makarova N.P.,Kalinina E.A. Informative value of oxidative stress markers in predicting outcomes of infertility treatment using ART methods. Obstetrics and Gynecology. 2022; (9): 64-70. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.9.64-70.
Moghadam A.R.E., Moghadam M.T., Hemadi M., Saki G. Oocyte quality and aging. JBRA Assist. Reprod. 2022;26(1):105-22. https://dx.doi.org/10.5935/1518-0557.20210026.
Hoque S.A.M., Kawai T., Zhu Z., Shimada M. Mitochondrial protein turnover is critical for granulosa cell proliferation and differentiation in antral follicles. J. Endocr. Soc. 2018; 3(2): 324-39. https://dx.doi.org/10.1210/js.2018-00329.
Wang L., Tang J., Wang L., Tan F., Song H., Zhou J., Li F. Oxidative stress in oocyte aging and female reproduction. J. Cell. Physiol. 2021; 236(12): 7966-83. https://dx.doi.org/10.1002/jcp.30468.
Colella M., Cuomo D., Peluso T., Falanga I., Mallardo M., De Felice M., Ambrosino C. Ovarian aging: role of pituitary-ovarian axis hormones and ncRNAs in regulating ovarian mitochondrial activity. Front. Endocrinol. (Lausanne). 2021; 12: 791071. https://dx.doi.org/10.3389/fendo.2021.791071.
Chiang J.L., Shukla P., Pagidas K., Ahmed N.S., Karri S., Gunn D.D. et al. Mitochondria in ovarian aging and reproductive longevity. Ageing Res. Rev. 2020; 63: 101168. https://dx.doi.org/10.1016/j.arr.2020.101168.
Spath M.A., Braat D.D.M. Iatrogenic and non-iatrogenic causes of female fertility loss that may indicate fertility preservation. Acta Obstet. Gynecol. Scand. 2019; 98(5): 559-62. https://dx.doi.org/10.1111/aogs.13594.
Viotti M. Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements. Genes (Basel). 2020; 11(6): 602. https://dx.doi.org/10.3390/genes11060602.
Vaiarelli A., Cimadomo D., Ubaldi N., Rienzi L., Ubaldi F.M. What is new in the management of poor ovarian response in IVF? Curr. Opin. Obstet. Gynecol. 2018; 30(3):155-62. https://dx.doi.org/10.1097/GCO.0000000000000452.
Alviggi C., Andersen C.Y., Buehler K., Conforti A., De Placido G., Esteves S.C.et al.; Poseidon Group (Patient-Oriented Strategies Encompassing Individualized Oocyte Number). A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil. Steril. 2016; 105(6): 1452-3. https://dx.doi.org/ 10.1016/j.fertnstert.2016.02.005.
Cedars M.I. Managing poor ovarian response in the patient with diminished ovarian reserve. Fertil. Steril. 2022; 117(4): 655-6. https://dx.doi.org/10.1016/j.fertnstert.2022.02.026.
Zhang Y., Zhang C., Shu J., Guo J., Chang H.M., Leung P.C.K. et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum. Reprod. Update. 2020; 26(2): 247-63.
Aggarwal B., Evans A.L., Ryan H., Martins da Silva S.J. IVF or ICSI for fertility preservation? Reprod. Fertil. 2021; 2(1): L1-L3. https://dx.doi.org/10.1530/RAF-20-0059.
Cai H., Ren W., Wang H., Shi J. Sex ratio imbalance following blastocyst transfer is associated with ICSI but not with IVF: an analysis of 14,892 single embryo transfer cycles. J. Assist. Reprod. Genet. 2022; 39(1): 211-8.https://dx.doi.org/10.1007/s10815-021-02387-8.
Practice Committee of the American Society for Reproductive Medicine. The role of assisted hatching in in vitro fertilization: a guideline. Fertil. Steril. 2022; 117(6): 1177-82. https://dx.doi.org/10.1016/j.fertnstert.2022.02.020.
Endo Y., Mitsuhata S., Hayashi M., Fujii Y., Motoyama H. Laser-assisted hatching on clinical and neonatal outcomes in patients undergoing single vitrified Blastocyst transfer: A propensity score-matched study. Reprod. Med. Biol. 2021; 20(2): 182-9. https://dx.doi.org/10.1002/rmb2.12366.
Mikwar M., MacFarlane A.J., Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat. Res. Rev. Mutat. Res. 2020; 785: 108320. https://dx.doi.org/10.1016/j.mrrev.2020.108320.
Kimelman D., Pavone M.E. Non-invasive prenatal testing in the context of IVF and PGT-A. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; 70: 51-62.https://dx.doi.org/ 10.1016/j.bpobgyn.2020.07.004.
Penzias A., Bendikson K., Butts S., Coutifaris C., Falcone T., Fossum G. et al.The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Ferti.l Steril. 2018; 109(3): 429-36 https://dx.doi.org/10.1016/j.fertnstert.2018.01.002.
Валиахметова Э.З., Кулакова Е.В., Скибина Ю.С., Грязнов А.Ю., Сысоева А.П., Макарова Н.П., Калинина Е.А. Неинвазивное тестирование преимплантационных эмбрионов человека in vitro как способ прогнозирования исходов программ экстракорпорального оплодотворения. Акушерство и гинекология. 2021; 5: 5-16. [Valiakhmetova E.Z., Kulakova E.V., Skibina Yu.S., Gryaznov A.Yu., Sysoeva A.P., Makarova N.P., Kalinina E.A. Non-invasive testing of human preimplantation embryos in vitro as a way to predict the outcomes of in vitro fertilization programs. Obstetrics and Gynecology. 2021; (5): 5-16. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.5.5-16.

Received 01.03.2023

Accepted 28.06.2023

Leah V. Khachatryan, postgraduate student of the Department of Obstetrics, Gynecology, Perinatology and Reproductology, Faculty of Postgraduate Professional Training
of Physicians, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), +7(963)977-88-94, leahkhachatryan@gmail.com,
https://orcid.org/0000-0003-4867-500X, 119991, Russia, Moscow, Trubetskaya str., 8-2.
Veronika Yu. Smolnikova, Dr. Med. Sci., Leading Researcher, Professor B.V. Leonov Department of Assistive Technologies in Infertility Treatment, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, v_smolnikova@oparina4.ru,
117997, Russia, Moscow, Ac. Oparin str., 4.
Natalya P. Makarova, PhD, Leading Researcher, Professor B.V. Leonov Department of Assistive Technologies in Infertility Treatment, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, np_makarova@oparina4.ru, https://orcid.org/0000-0003-8922-2878, 117997, Russia, Moscow, Ac. Oparin str., 4.

Live birth after using assisted reproductive technologies in a late reproductive-aged female patient with her own oocytes without preimplantation genetic testing for aneuploidies

Khachatryan L.V., Smolnikova V.Yu., Makarova N.P.

Keywords

References

About the Authors

Similar Articles